文献速递甲状腺疾病

甲状腺功能减退母亲妊娠及围产结局:基于人群的队列研究

Pregnancy and Perinatal Outcome Among Hypothyroid Mothers: A Population-Based Cohort Study.
PubMed 文献 · Thyroid · 2018-12-20

该研究基于芬兰2004–2013年571,785例单胎出生登记数据,比较16,364例甲减母亲与550,860例无甲状腺疾病母亲。甲减与妊娠期糖尿病、妊娠期高血压、重度子痫前期、剖宫产、早产、大于胎龄儿、重大先天畸形及新生儿重症监护入院风险升高相关;持续购买左甲状腺素(LT4)者仅剩部分关联。

要点

  • 甲减母亲多种妊娠及围产并发症风险升高。
  • 持续LT4使用可能与多数风险降低相关。
  • 甲减孕妇应关注血糖、血压及胎儿生长监测。

核心结论

  • 母亲甲减与多种妊娠和围产并发症相关,持续LT4使用可能降低许多风险。

研究设计与样本

  • 芬兰全国登记-based队列,纳入2004–2013年全部单胎出生N=571,785例,甲减母亲n=16,364,无甲状腺疾病母亲N=550,860,采用logistic回归比较。

主要发现

  • 甲减与妊娠期糖尿病(OR=1.19,CI 1.13-1.25)、妊娠期高血压(OR=1.20,CI 1.10-1.30)、重度子痫前期(OR=1.38,CI 1.15-1.65)相关。
  • 甲减与剖宫产(OR=1.22,CI 1.17-1.27)、早产(OR=1.25,CI 1.16-1.34)、大于胎龄儿(OR=1.30,CI 1.19-1.42)相关。
  • 甲减与重大先天畸形(OR=1.14,CI 1.06-1.22)及新生儿重症监护入院(OR=1.23,CI 1.17-1.29)相关。
  • 持续购买LT4者仅妊娠期糖尿病(OR=1.12,CI 1.03-1.22)、剖宫产(OR=1.13,CI 1.06-1.21)、新生儿重症监护入院(OR=1.09,CI 1.01-1.29)及大于胎龄儿(OR=1.26,CI 1.10-1.45)与甲减的关联仍存在。

关键数值与推荐

  • 甲减母亲中95.8%使用LT4药物,37.5%在妊娠期间持续使用LT4。

临床怎么用

  • 对甲减孕妇应重视妊娠期糖尿病、高血压、子痫前期、早产及胎儿生长监测,并强调持续LT4治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal hypothyroidism has been associated with adverse pregnancy outcomes. A large nationwide register-based cohort with data on medication purchases was established to study the associations between maternal hypothyroidism, levothyroxine (LT4) use, and pregnancy and perinatal complications. METHODS: The data included all singleton births between 2004 and 2013 (N = 571,785) in Finland. Hypothyroid mothers (n = 16,364) were identified in the Finnish Medical Birth Register. Of these women, 95.8% used LT4 medication, and 37.5% had consistent LT4 use during pregnancy. Hypothyroid mothers were compared to mothers without thyroid disease (N = 550,860) using logistic regression. The main outcome measures were pregnancy and perinatal complications. RESULTS: Maternal hypothyroidism was associated with several pregnancy and perinatal complications, including gestational diabetes mellitus (odds ratio [OR] = 1.19 [confidence interval (CI) 1.13-1.25]), gestational hypertension (OR = 1.20 [CI 1.10-1.30]), severe preeclampsia (OR = 1.38 [CI 1.15-1.65]), cesarean section (OR = 1.22 [CI 1.17-1.27]), preterm births (OR = 1.25 [CI 1.16-1.34]), large-for-gestational age newborns (OR = 1.30 [CI 1.19-1.42]), major congenital anomalies (OR = 1.14 [CI 1.06-1.22]), and neonatal intensive care unit admission (OR = 1.23 [CI 1.17-1.29]). However, among mothers with consistent LT4 purchases, only the associations between gestational diabetes mellitus (OR = 1.12 [CI 1.03-1.22]), cesarean section (OR = 1.13 [CI 1.06-1.21]), neonatal intensive care unit admission (OR = 1.09 [CI 1.01-1.29]), and large-for-gestational age newborns (OR = 1.26 [CI 1.10-1.45]) and maternal hypothyroidism remained. CONCLUSIONS: Maternal hypothyroidism is associated with several pregnancy and perinatal complications, but consistent LT4 use may reduce many of the risks.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Turunen S, Vääräsmäki M, Männistö T, et al. Pregnancy and Perinatal Outcome Among Hypothyroid Mothers: A Population-Based Cohort Study. Thyroid. 2018. PMID: 30417761. doi:10.1089/thy.2018.0311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。